These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6240636)

  • 1. Syntheses of 18F-labeled pyrimidines and their usefulness for tumor imaging.
    Ishiwata K; Ido T; Takahashi T; Monma M; Iwata R; Abe Y; Matsuzawa T; Tsurumi Y; Kameyama M
    Nucleic Acids Symp Ser; 1984; (15):25-8. PubMed ID: 6240636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.
    Ishiwata K; Ido T; Abe Y; Matsuzawa T; Murakami M
    Eur J Nucl Med; 1985; 10(1-2):39-44. PubMed ID: 3156740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
    Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
    Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.
    Abe Y; Fukuda H; Ishiwata K; Yoshioka S; Yamada K; Endo S; Kubota K; Sato T; Matsuzawa T; Takahashi T; Ido T
    Eur J Nucl Med; 1983; 8(6):258-61. PubMed ID: 6223818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
    Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
    J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.
    Ishiwata K; Yamaguchi K; Kameyama M; Fukuda H; Tada M; Matsuzawa T; Muraishi K; Itoh J; Kawashima K; Takahashi T
    Int J Rad Appl Instrum B; 1989; 16(3):247-54. PubMed ID: 2785512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-5-Fluorouridine, a new probe for measuring the proliferation of tissue in vivo.
    Crawford EJ; Friedkin M; Wolf AP; Fowler JS; Gallagher BM; Lambrecht RM; MacGregor RR; Shiue CY; Wodinsky I; Goldin A
    Adv Enzyme Regul; 1982; 20():3-22. PubMed ID: 6180608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital tumor diagnosis by positron emission tomography using 18F-fluorodeoxyuridine.
    Kiyosawa M; Mizuno K; Ishiwata K; Watanuki S; Monma M; Ido T; Abe Y; Fukuda H; Matsuzawa T
    Ophthalmic Res; 1986; 18(5):292-8. PubMed ID: 2949186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fates of 2'-deoxy-5-[18F]fluorouridine in tumor-bearing mice and human plasma.
    Ishiwata K; Sato K; Kameyama M; Yoshimoto T; Ido T
    Int J Rad Appl Instrum B; 1991; 18(5):539-45. PubMed ID: 1833361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.
    Barberi-Heyob M; Weber B; Merlin JL; Dittrich C; de Bruijn EA; Luporsi E; Guillemin F
    Cancer Chemother Pharmacol; 1995; 37(1-2):110-6. PubMed ID: 7497579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine.
    Kubota K; Ishiwata K; Kubota R; Yamada S; Takahashi J; Abe Y; Fukuda H; Ido T
    J Nucl Med; 1996 Feb; 37(2):320-5. PubMed ID: 8667070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
    Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
    J Nucl Med; 1994 Jun; 35(6):1067-75. PubMed ID: 8195872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
    Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
    J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
    Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
    J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.
    Ishiwata K; Ido T; Kawamura M; Kubota K; Ichihashi M; Mishima Y
    Int J Rad Appl Instrum B; 1991; 18(7):745-51. PubMed ID: 1787083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
    el Kouni MH; el Kouni MM; Naguib FN
    Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.